Keap1 hypomorphism protects against ischemic and obstructive kidney disease

Roderick J. Tan, Dionysios V. Chartoumpekis, Brittney M. Rush, Dong Zhou, Haiyan Fu, Thomas W. Kensler, Youhua Liu

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


The Keap1/Nrf2 pathway is a master regulator of antioxidant, anti-inflammatory, and other cytoprotective mechanisms important in protection from kidney disease. For the first time in kidney disease, we describe the use of Keap1 hypomorphic mice, which possess Nrf2 hyperactivation. We exposed these mice and wild type controls to ischemia/reperfusion injury (IRI). The initial tubular injury at 24 hours post-IRI appeared to be unaffected, with the only observed difference being a decrease in inflammatory cytokine expression in the hypomorphs. However, we noted significant improvement in serum creatinine in the hypomorphs at 3 and 10 days after injury, and renal fibrosis was dramatically attenuated at the late timepoint. Assessment of Nrf2-regulated targets (GSTM1, GSTP1, NQO1) revealed higher expression in the hypomorphs at baseline. While injury tended to suppress these genes in wild-type mice, the suppression was attenuated or reversed in Keap1 hypomorphs, suggesting that protection in these mice was mediated by increased Nrf2 transcriptional activity. To assess the generalizability of our findings, we subjected the hypomorphs to unilateral ureteral obstruction (UUO) and again found significant protection and increased expression of Nrf2 targets. Overall, these results support the conclusion that the Nrf2 pathway is protective in a variety of kidney diseases.

Original languageEnglish (US)
Article number36185
JournalScientific reports
StatePublished - Nov 2 2016
Externally publishedYes

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Keap1 hypomorphism protects against ischemic and obstructive kidney disease'. Together they form a unique fingerprint.

Cite this